Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INSERM UMR 1163, Imagine Institute, Paris, France.
Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INSERM UMR 1163, Imagine Institute, Paris, France; Université de Paris-Cité, Paris, France.
J Allergy Clin Immunol. 2024 Jul;154(1):229-236.e2. doi: 10.1016/j.jaci.2024.01.029. Epub 2024 Mar 2.
Immune dysregulation often presents as autoimmunity, inflammation, and/or lymphoproliferation. Several germline genetic defects have been associated with immune dysregulation; they include heterozygous gain-of-function (GOF) mutations in IKZF1, an essential transcription factor for hematopoiesis containing zinc finger domains (ZFs). However, in a large percentage of patients, the genetic origin of their immunedysregulation remains undetermined.
A family with 2 members presenting immune dysregulation signs was studied to identify the genetic cause of their disease.
Whole exome sequencing, analysis of immunologic parameters, and functional assays (including Western blotting, electrophoretic mobility shift assay during the cell cycle, and T cell differentiation) were performed.
The 2 patients carried a novel heterozygous mutation in IKZF1 (IKZF1). IKZF1 heterozygous mutations have previously been shown to be responsible for several distinct human immunologic diseases by directly affecting the ability of ZFs to bind to DNA or to dimerize. Herein, we showed that the IKZF1, which is outside the ZFs, caused impaired phosphorylation of IKZF1, resulting in enhanced DNA-binding ability at the S phase of the cell cycle, reduction of the G1-S phase transition, and decreased proliferation. Confirming these data, similar functional alterations were observed with IKZF1, but not with IKZF1, mimicking dephosphorylation and phosphorylation, respectively. In T lymphocytes, expression of IKZF1 led to T cell differentiation skewed toward T2 cells. Thus, our data indicate that IKZF1 behaves as a GOF variant underlying immune dysregulation.
Disturbed IKZF1 phosphorylation represents a novel GOF mechanism (GOF by loss of phosphorylation (termed as GOF-LOP) associated with immune dysregulation, highlighting the regulatory role of IKZF1 during cell cycle progression through phosphorylation.
免疫失调常表现为自身免疫、炎症和/或淋巴增生。几种种系遗传缺陷与免疫失调有关;它们包括造血必需转录因子 IKZF1 的杂合功能获得性 (GOF) 突变,IKZF1 含有锌指结构域 (ZF)。然而,在很大比例的患者中,其免疫失调的遗传起源仍未确定。
研究了一个有 2 名成员表现出免疫失调迹象的家族,以确定其疾病的遗传原因。
进行了全外显子组测序、免疫参数分析和功能测定(包括 Western 印迹、细胞周期中的电泳迁移率变动分析和 T 细胞分化)。
这 2 名患者携带 IKZF1(IKZF1)的新型杂合突变。IKZF1 杂合突变以前通过直接影响 ZF 与 DNA 结合或二聚化的能力而被证明是几种不同的人类免疫性疾病的原因。在此,我们表明 IKZF1 位于 ZFs 之外,导致 IKZF1 的磷酸化受损,从而在细胞周期的 S 期增强 DNA 结合能力,减少 G1-S 期转变,并降低增殖。证实了这些数据,分别模拟去磷酸化和磷酸化的 IKZF1 而不是 IKZF1 观察到类似的功能改变。在 T 淋巴细胞中,IKZF1 的表达导致 T 细胞分化偏向 T2 细胞。因此,我们的数据表明 IKZF1 作为免疫失调的 GOF 变体起作用。
IKZF1 磷酸化的紊乱代表了一种新的 GOF 机制(通过失磷酸化的 GOF(称为与免疫失调相关的 GOF-LOP),强调了 IKZF1 在通过磷酸化进行细胞周期进展中的调节作用。